| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222624 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 8 Pages |
Abstract
Pelvic IMRT with weekly cisplatin is associated with low rates of HT and high rates of weekly cisplatin use. The volume of bone marrow receiving 40 Gy and the median dose to bone marrow correlated with higher rates of grade â¥2 toxicity among patients receiving weekly cisplatin (cervical cancer patients). Evaluation and limitation of the volume of bone marrow treated with pelvic IMRT is warranted in patients receiving concurrent chemotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ann H. MD, PhD, Jennifer MS, Lorraine MD, Brigitte E. MD, Mohammad R. PhD, Evangeline CMD, BS, Jenny CMD, BS, David MD, Luis MD, William MD, Rakesh MD, MPH, Anuja MD,